BEVACIZUMAB FOR RECURRENT HIGH-GRADE GLIOMA (HGG): ANALYSIS OF MONOTHERAPY VERSUS COMBINATION WITH CHEMOTHERAPY FROM A CANADIAN RETROSPECTIVE CHART REVIEW

被引：0
|
作者：
Kavan, Petr [1 ]
Sahebjam, Solmaz [2 ]
Garoufalis, Evgenia [3 ]
Guiot, Marie-Christine [4 ]
Muanza, Thierry
Del Maestro, Rolando [5 ]
Petrecca, Kevin [5 ]
Sharma, Rajesh [3 ]
机构：
[1] McGill Univ, Royal Victoria Hosp, Ctr Hlth, Montreal, PQ H3A 1A1, Canada
[2] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
[3] McGill Univ, Ctr Hlth, Montreal, PQ, Canada
[4] Montreal Neurol Hosp, Inst Neuropathol, Montreal, PQ, Canada
[5] McGill Univ, Ctr Hlth, Montreal Neurol Inst & Hosp, Montreal, PQ, Canada
来源：
NEURO-ONCOLOGY | 2012年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：76 / 76
页数：1
相关论文
共 50 条
  • [31] Concomitant Temozolomide plus radiotherapy for high-grade and recurrent meningioma: a retrospective chart review
    Belanger, Katherine
    Ung, Timothy H.
    Damek, Denise
    Lillehei, Kevin O.
    Ormond, D. Ryan
    BMC CANCER, 2022, 22 (01)
  • [32] Reirradiation versus systemic therapy for recurrent high-grade glioma: A systematic review
    Marwah, R.
    Xing, D.
    Soon, Y. Y.
    Squire, T.
    Gan, H.
    Ng, S. P.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S909 - S910
  • [33] RETROSPECTIVE ANALYSIS OF CARBOPLATINUM AND BEVACIZUMAB CHEMOTHERAPY IN PATIENTS WITH RECURRENT GLIOMA
    Fink, Karen
    Nestor, Vanessa
    Daoud, Yahya
    NEURO-ONCOLOGY, 2008, 10 (05) : 825 - 825
  • [34] Phase I study of plerixafor and bevacizumab in recurrent high-grade glioma
    Smith, Katrina H.
    Lee, Eudocia Quant
    Muzikansky, Alona
    Robins, Elizabeth
    Duda, Gerstner Dan G.
    Reardon, David A.
    Nayak, Lakshmi
    Norden, Andrew David
    Doherty, Lisa M.
    Rifenburg, Jennifer
    LaFrankie, Debra C.
    Ruland, Sandra
    Pulverenti, Julee
    Stokes, Deirdre
    Lam, Priscilla
    McCluskey, Christine Sceppa
    Gaffey, Sarah C.
    Batchelor, Tracy
    Jain, Ftakesh K.
    Wen, Patrick Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [35] Late-line treatment with bevacizumab alone or in combination with chemotherapy in recurrent high-grade gliomas
    Mehdi Yahia-Cherif
    Sylvie Luce
    Olivier De Witte
    Niloufar Sadeghi-Meibodi
    Gil Leurquin-Sterk
    Florence Lefranc
    Acta Neurochirurgica, 2023, 165 : 693 - 699
  • [36] Late-line treatment with bevacizumab alone or in combination with chemotherapy in recurrent high-grade gliomas
    Yahia-Cherif, Mehdi
    Luce, Sylvie
    De Witte, Olivier
    Sadeghi-Meibodi, Niloufar
    Leurquin-Sterk, Gil
    Lefranc, Florence
    ACTA NEUROCHIRURGICA, 2023, 165 (03) : 693 - 699
  • [37] Bevacizumab Use for Recurrent High-Grade Glioma at McGill University Hospital
    Sahebjam, Solmaz
    Garoufalis, Evgenia
    Guiot, Marie-Christine
    Muanza, Thierry
    Del Maestro, Rolando
    Petrecca, Kevin
    Sharma, Rajesh
    Kavan, Petr
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2013, 40 (02) : 241 - 246
  • [38] PHASE I STUDYOF PLERIXAFOR AND BEVACIZUMAB IN RECURRENT HIGH-GRADE GLIOMA
    Lee, Eudocia
    Smith, Katrina
    Muzikansky, Alona
    Gerstner, Elizabeth
    Kuhn, John
    Reardon, David
    Nayak, Lakshmi
    Norden, Andrew
    Rifenburg, Jennifer
    Pulverenti, Julee
    Stokes, Deirdre
    Lam, Priscilla
    Martins, Tiago
    Hempfling, Kelly
    McCluskey, Christine
    Gaffey, Sarah
    Batchelor, Tracy
    Duda, Dan
    Jain, Rakesh
    Wen, Patrick
    NEURO-ONCOLOGY, 2014, 16
  • [39] Single-agent bevacizumab for recurrent high-grade glioma.
    Greally, Megan
    Cadoo, Karen Anne
    Coleman, Niamh
    O'Brien, Michelle
    O'Riordan, Lynda M.
    Grogan, William
    Breathnach, Oscar S.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [40] Bevacizumab and dose-intense temozolomide in recurrent high-grade glioma
    Verhoeff, J. J. C.
    Lavini, C.
    van Linde, M. E.
    Stalpers, L. J. A.
    Majoie, C. B. L. M.
    Reijneveld, J. C.
    van Furth, W. R.
    Richel, D. J.
    ANNALS OF ONCOLOGY, 2010, 21 (08) : 1723 - 1727
12345